Tokyo Tape
Sign in
← M3

Annual report

2413.TEDINET S100OJCD
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥208.2bn2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥169.2bn2020-04-01 → 2021-03-31Cons.Revenue IFRS
Revenue¥131.0bn2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥113.1bn2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥94.5bn2017-04-01 → 2018-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥95.1bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Operating income¥58.0bn2020-04-01 → 2021-03-31Cons.Operating profit loss IFRS
Profit before tax¥96.2bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥58.3bn2020-04-01 → 2021-03-31Cons.Profit loss before tax IFRS
Profit before tax¥34.6bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥30.9bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥27.5bn2017-04-01 → 2018-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥63.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥37.8bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥21.6bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥19.6bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥18.1bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥66.1bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Net income¥41.2bn2020-04-01 → 2021-03-31Cons.Profit loss IFRS
Total assets¥346.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥273.1bnat 2021-03-31Cons.Assets IFRS
Total assets¥221.8bnat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥137.3bnat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥116.4bnat 2018-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥82.0bnat 2022-03-31Cons.Liabilities IFRS
Total liabilities¥65.9bnat 2021-03-31Cons.Liabilities IFRS
Net assets / equity¥264.0bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥207.3bnat 2021-03-31Cons.Equity IFRS
Net assets / equity¥171.6bnat 2020-03-31dCons.Equity IFRS
Equity (owners)¥257.8bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥199.8bnat 2021-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥166.1bnat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥98.7bnat 2019-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥82.5bnat 2018-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥104.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥89.1bnat 2021-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥47.9bnat 2020-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥27.5bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥23.7bnat 2018-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥52.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥46.6bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥26.8bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥17.7bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥15.9bn2017-04-01 → 2018-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥23.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥3.6bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥49.9bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥8.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥7.3bn2017-04-01 → 2018-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥16.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥11.6bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥43.4bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥5.0bn2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥4.8bn2017-04-01 → 2018-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥94.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥55.732020-04-01 → 2021-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥31.892019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥30.222018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥27.992017-04-01 → 2018-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥93.982021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥55.682020-04-01 → 2021-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥31.882019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥30.22018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥27.972017-04-01 → 2018-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥378.75at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥293.64at 2021-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥244.24at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥151.97at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥126.97at 2018-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio74.5%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio73.2%at 2021-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.9%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.9%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio70.8%at 2018-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE27.9%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE20.7%2020-04-01 → 2021-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE16.3%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE21.6%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE24.2%2017-04-01 → 2018-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees9,384at 2022-03-31Cons.Number of employees
Employees8,249at 2021-03-31Cons.Number of employees
Employees7,127at 2020-03-31dCons.Number of employees
Employees6,024at 2019-03-31dCons.Number of employees
Employees5,165at 2018-03-31dCons.Number of employees
Revenue¥55.7bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥49.9bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥27.0bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥22.2bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥22.2bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥27.5bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income¥28.0bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥32.3bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥30.8bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥17.7bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥12.2bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥16.6bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥28.6bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥30.7bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥20.5bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥22.0bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥12.2bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥8.9bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥12.0bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥215.4bnat 2022-03-31StandaloneAssets
Total assets¥195.4bnat 2021-03-31StandaloneAssets
Total assets¥163.2bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥97.8bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥83.9bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥62.9bnat 2022-03-31StandaloneLiabilities
Total liabilities¥55.6bnat 2021-03-31StandaloneLiabilities
Net assets / equity¥152.5bnat 2022-03-31StandaloneNet assets
Net assets / equity¥139.8bnat 2021-03-31StandaloneNet assets
Net assets / equity¥122.9bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥65.8bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥59.0bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥92.6bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥80.3bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥30.172021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥32.412020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥18.032019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥13.672018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥18.522017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥30.152021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥32.382020-04-01 → 2021-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥18.022019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥13.662018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥18.512017-04-01 → 2018-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥162021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥122020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥8.52019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥72018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥112017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥223.54at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥205.3at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥180.54at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥101.23at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥90.65at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio70.4%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.3%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio75.1%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio67.1%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio70.0%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE14.1%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE16.8%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE13.0%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE14.2%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE21.8%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued678,904,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued678,785,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued678,645,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued647,957,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued323,897,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees574at 2022-03-31StandaloneNumber of employees
Employees554at 2021-03-31StandaloneNumber of employees
Employees473at 2020-03-31dStandaloneNumber of employees
Employees421at 2019-03-31dStandaloneNumber of employees
Employees364at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 60
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2021-04-01 → 2022-03-31−¥5.0bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2022-03-31−¥5.0bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥2.3bn
Career Solutionreportable segmentemployeesat 2022-03-31627 pure
Career Solutionreportable segmentrevenue2021-04-01 → 2022-03-31¥14.1bn
Career Solutionreportable segmentrevenue external2021-04-01 → 2022-03-31¥13.4bn
Career Solutionreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥740m
Career Solutionreportable segmentsegment profit2021-04-01 → 2022-03-31¥4.6bn
Evidence Solutionreportable segmentemployeesat 2022-03-312181 pure
Evidence Solutionreportable segmentrevenue2021-04-01 → 2022-03-31¥22.8bn
Evidence Solutionreportable segmentrevenue external2021-04-01 → 2022-03-31¥21.9bn
Evidence Solutionreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥856m
Evidence Solutionreportable segmentsegment profit2021-04-01 → 2022-03-31¥5.7bn
Medical Platformreportable segmentemployeesat 2022-03-311754 pure
Medical Platformreportable segmentrevenue2021-04-01 → 2022-03-31¥85.9bn
Medical Platformreportable segmentrevenue external2021-04-01 → 2022-03-31¥83.2bn
Medical Platformreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥2.7bn
Medical Platformreportable segmentsegment profit2021-04-01 → 2022-03-31¥39.6bn
Overseasreportable segmentemployeesat 2022-03-312117 pure
Overseasreportable segmentrevenue2021-04-01 → 2022-03-31¥51.8bn
Overseasreportable segmentrevenue external2021-04-01 → 2022-03-31¥51.8bn
Overseasreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥20m
Overseasreportable segmentsegment profit2021-04-01 → 2022-03-31¥44.8bn
Site Solutionreportable segmentemployeesat 2022-03-312470 pure
Site Solutionreportable segmentrevenue2021-04-01 → 2022-03-31¥35.2bn
Site Solutionreportable segmentrevenue external2021-04-01 → 2022-03-31¥34.7bn
Site Solutionreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥525m
Site Solutionreportable segmentsegment profit2021-04-01 → 2022-03-31¥3.4bn
—segment totalrevenue2021-04-01 → 2022-03-31¥209.8bn
—segment totalrevenue external2021-04-01 → 2022-03-31¥204.9bn
—segment totalrevenue intersegment2021-04-01 → 2022-03-31¥4.9bn
—segment totalsegment profit2021-04-01 → 2022-03-31¥98.1bn
Reconciling Itemsreconcilingrevenue2020-04-01 → 2021-03-31−¥2.9bn
Reconciling Itemsreconcilingrevenue intersegment2020-04-01 → 2021-03-31−¥2.9bn
Reconciling Itemsreconcilingsegment profit2020-04-01 → 2021-03-31−¥2.4bn
Career Solutionreportable segmentrevenue2020-04-01 → 2021-03-31¥13.5bn
Career Solutionreportable segmentrevenue external2020-04-01 → 2021-03-31¥13.5bn
Career Solutionreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥46m
Career Solutionreportable segmentsegment profit2020-04-01 → 2021-03-31¥3.8bn
Evidence Solutionreportable segmentrevenue2020-04-01 → 2021-03-31¥19.5bn
Evidence Solutionreportable segmentrevenue external2020-04-01 → 2021-03-31¥19.0bn
Evidence Solutionreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥520m
Evidence Solutionreportable segmentsegment profit2020-04-01 → 2021-03-31¥3.6bn
Medical Platformreportable segmentrevenue2020-04-01 → 2021-03-31¥77.1bn
Medical Platformreportable segmentrevenue external2020-04-01 → 2021-03-31¥74.8bn
Medical Platformreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥2.3bn
Medical Platformreportable segmentsegment profit2020-04-01 → 2021-03-31¥37.9bn
Overseasreportable segmentrevenue2020-04-01 → 2021-03-31¥42.1bn
Overseasreportable segmentrevenue external2020-04-01 → 2021-03-31¥42.1bn
Overseasreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥14m
Overseasreportable segmentsegment profit2020-04-01 → 2021-03-31¥12.6bn
Site Solutionreportable segmentrevenue2020-04-01 → 2021-03-31¥16.6bn
Site Solutionreportable segmentrevenue external2020-04-01 → 2021-03-31¥16.6bn
Site Solutionreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥1m
Site Solutionreportable segmentsegment profit2020-04-01 → 2021-03-31¥1.5bn
—segment totalrevenue2020-04-01 → 2021-03-31¥168.8bn
—segment totalrevenue external2020-04-01 → 2021-03-31¥166.0bn
—segment totalrevenue intersegment2020-04-01 → 2021-03-31¥2.8bn
—segment totalsegment profit2020-04-01 → 2021-03-31¥59.4bn
Medical Platformreportable segmentemployeesat 2022-03-31479 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,643
ItemContextValueUnit
Impairment losses pl IFRSPrior1YearDuration_jpcrp030000-asr_E05425-000OverseasReportableSegmentMember－JPY
Impairment losses pl IFRSPrior1YearDuration_ReportableSegmentsMember820000000JPY
Impairment losses pl IFRSPrior1YearDuration_jpcrp030000-asr_E05425-000OtherEmergingBusinessMember－JPY
Impairment losses pl IFRSPrior1YearDuration_ReconcilingItemsMember－JPY
Impairment losses pl IFRSPrior1YearDuration820000000JPY
Revenue from external customers IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000MedicalPlatformReportableSegmentMember83180000000JPY
Revenue from external customers IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000EvidenceSolutionReportableSegmentMember21899000000JPY
Revenue from external customers IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000CareerSolutionReportableSegmentMember13353000000JPY
Revenue from external customers IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000SiteSolutionReportableSegmentMember34660000000JPY
Revenue from external customers IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OverseasReportableSegmentMember51811000000JPY
Revenue from external customers IFRSCurrentYearDuration_ReportableSegmentsMember204903000000JPY
Revenue from external customers IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OtherEmergingBusinessMember3256000000JPY
Revenue from external customers IFRSCurrentYearDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSCurrentYearDuration208159000000JPY
Intersegment revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000MedicalPlatformReportableSegmentMember2749000000JPY
Intersegment revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000EvidenceSolutionReportableSegmentMember856000000JPY
Intersegment revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000CareerSolutionReportableSegmentMember740000000JPY
Intersegment revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000SiteSolutionReportableSegmentMember525000000JPY
Intersegment revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OverseasReportableSegmentMember20000000JPY
Intersegment revenue IFRSCurrentYearDuration_ReportableSegmentsMember4890000000JPY
Intersegment revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OtherEmergingBusinessMember104000000JPY
Intersegment revenue IFRSCurrentYearDuration_ReconcilingItemsMember-4994000000JPY
Intersegment revenue IFRSCurrentYearDuration－JPY
Revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000MedicalPlatformReportableSegmentMember85928000000JPY
Revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000EvidenceSolutionReportableSegmentMember22756000000JPY
Revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000CareerSolutionReportableSegmentMember14094000000JPY
Revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000SiteSolutionReportableSegmentMember35184000000JPY
Revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OverseasReportableSegmentMember51831000000JPY
Revenue IFRSCurrentYearDuration_ReportableSegmentsMember209793000000JPY
Revenue IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OtherEmergingBusinessMember3360000000JPY
Revenue IFRSCurrentYearDuration_ReconcilingItemsMember-4994000000JPY
Revenue IFRSCurrentYearDuration208159000000JPY
Operating profit loss IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000MedicalPlatformReportableSegmentMember39553000000JPY
Operating profit loss IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000EvidenceSolutionReportableSegmentMember5654000000JPY
Operating profit loss IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000CareerSolutionReportableSegmentMember4646000000JPY
Operating profit loss IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000SiteSolutionReportableSegmentMember3399000000JPY
Operating profit loss IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OverseasReportableSegmentMember44837000000JPY
Operating profit loss IFRSCurrentYearDuration_ReportableSegmentsMember98091000000JPY
Operating profit loss IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OtherEmergingBusinessMember-601000000JPY
Operating profit loss IFRSCurrentYearDuration_ReconcilingItemsMember-2348000000JPY
Operating profit loss IFRSCurrentYearDuration95141000000JPY
Finance income and expenses net IFRSCurrentYearDuration1045000000JPY
Profit loss before tax IFRSCurrentYearDuration96187000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000MedicalPlatformReportableSegmentMember-69000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000EvidenceSolutionReportableSegmentMember－JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000CareerSolutionReportableSegmentMember－JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000SiteSolutionReportableSegmentMember－JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OverseasReportableSegmentMember-30000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYearDuration_ReportableSegmentsMember-99000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYearDuration_jpcrp030000-asr_E05425-000OtherEmergingBusinessMember-2331000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass